Cite
Serial measurement of interleukin-6 and risk of mortality in anticoagulated patients with atrial fibrillation: Insights from ARISTOTLE and RE-LY trials.
MLA
Aulin, Julia, et al. “Serial Measurement of Interleukin-6 and Risk of Mortality in Anticoagulated Patients with Atrial Fibrillation: Insights from ARISTOTLE and RE-LY Trials.” Journal of Thrombosis and Haemostasis : JTH, vol. 18, no. 9, Sept. 2020, pp. 2287–95. EBSCOhost, https://doi.org/10.1111/jth.14947.
APA
Aulin, J., Hijazi, Z., Siegbahn, A., Andersson, U., Alexander, J. H., Connolly, S. J., Ezekowitz, M. D., Gersh, B. J., Granger, C. B., Horowitz, J., Hylek, E. M., Lopes, R. D., Yusuf, S., Wallentin, L., & Oldgren, J. (2020). Serial measurement of interleukin-6 and risk of mortality in anticoagulated patients with atrial fibrillation: Insights from ARISTOTLE and RE-LY trials. Journal of Thrombosis and Haemostasis : JTH, 18(9), 2287–2295. https://doi.org/10.1111/jth.14947
Chicago
Aulin, Julia, Ziad Hijazi, Agneta Siegbahn, Ulrika Andersson, John H Alexander, Stuart J Connolly, Michael D Ezekowitz, et al. 2020. “Serial Measurement of Interleukin-6 and Risk of Mortality in Anticoagulated Patients with Atrial Fibrillation: Insights from ARISTOTLE and RE-LY Trials.” Journal of Thrombosis and Haemostasis : JTH 18 (9): 2287–95. doi:10.1111/jth.14947.